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Nisin is a posttranslationally modified antimicrobial peptide
containing the cyclic thioether amino acids lanthionine and
methyllanthionine. Although much is known about its antimi-
crobial activity and mode of action, knowledge about the nisin
modification process is still rather limited. The dehydratase
NisB is believed to be the initial interaction partner in modifi-
cation. NisB dehydrates specific serine and threonine residues
in prenisin, whereas the cyclase NisC catalyzes the (methyl)lan-
thionine formation. The fully modified prenisin is exported and
the leader peptide is cleaved off by the extracellular protease
NisP. Light scattering analysis demonstrated that purified NisB
is a dimer in solution. Using size exclusion chromatography and
surface plasmon resonance, the interaction of NisB and preni-
sin, including several of its modified derivatives, was studied.
Unmodified prenisin binds to NisB with an affinity of 1.05 
0.25 M, whereas the dehydrated and the fully modified deriva-
tives bindwith respective affinities of 0.31 0.07 and 10.5 1.7
M. The much lower affinity for the fully modified prenisin was
related to a >20-fold higher off-rate. For all three peptides the
stoichiometry of binding was 1:1. Active nisin, which is the
equivalent of fully modified prenisin lacking the leader peptide
did not bind to NisB, nor did prenisin in which the highly con-
served FNLD box within the leader peptide was mutated to
AAAA. Taken together our data indicate that the leader peptide
is essential for initial recognition and binding of prenisin to
NisB.
Thedevelopment of bacterial resistance against clinically rel-
evant antibiotics is on the rise and represents a major scientific
challenge (1). There is an ever growing demand for novel and
improved antimicrobial agents. As potential antibiotics, bacte-
ricidal peptides that are secreted by many bacteria, mainly for
self-defense purposes, have gained special interest (2). Among
these are the so-called lantibiotics, which are ribosomally syn-
thesized peptides that are posttranslationally modified (3) and
produced by a large number of Gram-positive bacteria.
Nisin, probably the most well known lantibiotic, is produced
by the Gram-positive bacterium Lactococcus lactis and its anti-
microbial activity is directed against microorganisms of similar
type. Nisin has been used for more than 40 years as a food
preservative, but so far, no significant bacterial resistance has
arisen. Recently, L. lactis subspecies have been identified that
are capable to inactivate nisin via proteolytic cleavage (4).
Nisin exerts its bactericidal mode of action in a dual fashion.
First, nisin inhibits bacterial cell-wall synthesis by binding to lipid
II, an essential cell-wall precursormolecule (5). Second, binding to
lipid II leads to the formation of lipid II-nisin hybrid pores, which
depolarizes and permeabilizes the cytoplasmic membrane of the
target cell, leading to starvation and cell death (6–8).
The nisin biosynthesis operon comprises the nisin structural
gene nisA and genes involved in modification (nisB and nisC),
transport (nisT), and activation via processing (nisP) (9). Nisin
biosynthesis is autoregulated via the two-component system
nisRK (10, 11), whereas the autoimmunity factors of L. lactis are
encoded by genes nisFEG and nisI (12). For the maturation of
nisin, the 57-amino acid prenisin peptide (NisA) requires mod-
ification by several enzymes. The dehydratase NisB catalyzes
the dehydration of specific serine and threonine residues to
didehydroalanine and didehydrobutyrine residues, respectively
(13, 14). These, in turn, are stereospecifically coupled to cys-
teines by the cyclase NisC (14, 15) yielding five thioether rings
(13–15). Finally, the fully modified prenisin is secreted by the
ATP-binding cassette transporter NisT (16, 17) and extracellu-
larly processed by the cell-wall anchored protease NisP to lib-
erate active nisin. These modifications are schematically
depicted in Fig. 1 (18).
The dehydrataseNisB has a central role in nisin biosynthesis.
An increase of NisB expression leads to an enhanced dehydra-
tion efficiency of prenisin (19). NisB can, however, function in
the absence of the cyclaseNisC, producing dehydrated prenisin
devoid of thioether rings, whereas deletion of NisB results in a
substantially reduced production of (unmodified) prenisin (17).
Remarkably, NisB can also function in the absence of both the
cyclaseNisCandthe transporterNisT. L. lactiscells lackingNisCT
secreted dehydrated peptide when the nisin leader peptide is pre-
ceded by a Sec signal sequence (22). Yeast two-hybrid and co-
immunoprecipitation studies signified interactions betweenNisB,
NisC, and prenisin (9).
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Recent studies revealed that the modification of prenisin is a
progressive and directional process requiring NisB andNisC to
function cooperatively in an alternating fashion (20, 21). How-
ever, isolation of the proposed nisin modification complex
NisBC has so far been unsuccessful (9, 19).
NisB is capable of dehydrating therapeutic peptides (unre-
lated to nisin) that are fused C-terminal to the nisin leader pep-
tide (13, 22). Combined in vivo and in vitro data indicate that
the leader peptide is essential for NisB and NisC modification
(13, 15, 23) as well as for targeting the substrate peptide to the
dedicated transporter NisT (17, 24). In addition, it was demon-
strated that the leader peptide attached to the fully modified
lantibiotic abolishes its antimicrobial activity, suggesting also a
role in self-protection (15, 25).
The introduction of thioether rings in therapeutic peptides,
either via enzymatic activity (NisBC) or chemical synthesis, has
been shown to increase the resistance to proteolytic degrada-
tion (26, 27). Thus, a detailed understanding of the molecular
mechanisms involved in nisin modification might be very
important in the development of novel and improved peptide
antibiotics as well as clinically relevant peptides that may be
augmented by enzymatic posttranslational modification. How-
ever, whereasNisC cyclase activity has been successfully recon-
stituted in vitro and was shown to be independent of NisB and
NisT (15), thus far, an in vitro activity of NisB has not been
reported (2, 28).
Here we show a detailed biochemical and biophysical analy-
sis of NisB and its interaction with prenisin and its modified
derivatives, i.e. dehydrated and fully modified prenisin. Our
results provide strong experimental evidence that the leader
peptide and especially the FNLD box herein is a key determi-
nant in substrate recognition and specificity of NisB.
EXPERIMENTAL PROCEDURES
Expression and Purification of His-tagged NisB—L. lactis
NZ9000 containing the plasmid pNGnisBhis was grown over-
night in 100 ml of M17 medium containing 0.5% (w/v) glucose
(GM17) and 5 g/ml of chloramphenicol at 30 °C. Cells were
FIGURE 1. Posttranslationalmodification of nisin. For nisinmaturation, the ribosomally synthesized precursor peptide undergoes a series of modifications.
A, the leader peptide (in gray) directs the prenisin to the nisinmodification and transportmachinery. The conserved FNLDbox is highlighted in blue. B, specific
serine and threonine residues (highlighted in yellow) are converted by the dehydratase NisB into dehydroalanines (dha) and dehydrobutyrines (dhb), respec-
tively. C, the dehydrated residues, in turn, are specifically coupled to cysteine residues (highlighted in orange) by the cyclase NisC yielding five thioether rings
comprising one lanthionine (a) and four methyllanthionines (b-e). D, fully modified prenisin is subsequently exported by the ABC-type transporter NisT and
processed by the extracellular protease NisP that cleaves off the leader peptide to liberate active nisin. Note that Ser-29 is never dehydrated in nisin.
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transferred to 2 liters of fresh GM17 medium and growth was
continued to an A600 of 0.8, whereupon NisB expression was
induced by the addition of nisin (Sigma) to a final concentration
of 25 ng/ml. Three hours after induction cells were harvested by
centrifugation at 8000 g for 20 min at 4 °C. The cell pellet was
suspended in 14ml of buffer composed of 50mMHEPES-NaOH,
pH 8.0, and 150mMNaCl and stored at20 °C until use.
For purification, cells were thawed at 4 °C, supplemented
with protease inhibitor mixture (Roche Applied Science) and
DNase I (Sigma), and lysed with a cell disruptor (IUL Instru-
ments), generally 4–5 cycles at a pressure of 2.5 kbar. The
remaining cells were removed at 18,000 g for 30 min at 4 °C,
and the resulting supernatant was cleared from membranes by
centrifugation at 130,000 g for 75 min at 4 °C. The superna-
tant containingNisBwas supplementedwith imidazole, pH 8.0,
to a final concentration of 5 mM and incubated at 4 °C for 10
min. The solution was then loaded on a 5-ml HiTrap chelating
column (GE Healthcare) saturated with Ni2 ions, using a flow
rate of 2 ml/min at 4 °C. The column was washed with buffer
containing 50mMHEPES-NaOH, pH 8.0, 500mMNaCl, 10mM
imidazole, and 10% (v/v) glycerol followed by a wash step in
which the imidazole concentration was increased to 50 mM
imidazole to remove unspecifically bound proteins. Finally,
NisBwas step-eluted by increasing the imidazole concentration
to 250 mM using a flow rate of 1 ml/min. Eluted protein was
monitored by measuring the absorbance at 280 nm and ana-
lyzed by SDS-PAGE.NisB containing fractionswere pooled and
applied to a HiLoad 16/60 Superdex 200 (GE Healthcare) size
exclusion column using 50 mMHEPES-NaOH, pH 8.0, 500 mM
NaCl, and 10% (v/v) glycerol as elution buffer. NisB containing
fractions were pooled and concentrated with an Amicon Ultra-
centrifugal filter Ultracel (100 kDa cut-off). Protein concentra-
tion was determined by measuring the absorbance at 280 nm
with a NanoDrop ND-1000 spectrophotometer (peqlab) using
the theoretical extinction coefficient of NisB of 128,400 liters
mol1 cm1, as calculated for the His-tagged NisB using Prot-
Param webserver (EXPASY).
Expression and Purification of Prenisin and Its Derivatives—
Production of prenisin (NisA) and its derivatives was per-
formed with L. lactis strain NZ9000 containing pNZnisA-E3
(17) together with pIL3BTC (for fully modified prenisin) (29),
pIL3hpBT (for dehydrated prenisin) (30), or pIL3hpT (for
unmodified prenisin) (30) as described in Ref. 21. The FNLD/
AAAA mutant was produced as described in Ref. 24. Purifica-
tion of the various prenisin peptides was performed as
described in Ref. 21 with modifications. Cell-free medium con-
taining the peptide was diluted 1:1 with 50mM lactic acid, pH 3,
and subjected to SP-Sepharose chromatography. After peptide
binding, the lactic acid buffer, pH 3, was gradually changed to
50mMHEPES-NaOH, pH 7, by applying a gradient (0–100% 50
mMHEPES-NaOH, pH7) for 4 column volumes at a flow rate of
2ml/min followed by a wash step for 8 column volumes with 50
mMHEPES-NaOH, pH 7. At this stage, the eluent showed a pH
of 7. Finally, bound prenisin was eluted with 50 mM HEPES-
NaOH, pH 7, 1 M NaCl, and 10% (v/v) glycerol. Peptide elution
was monitored at 215 nm and fractions were analyzed by SDS-
PAGE. Prenisin containing fractions were pooled and filtered
through an Amicon Ultracentrifugal filter (30 kDa cut-off) to
remove high molecular mass contaminants. The flow-through
containing the prenisin was concentrated with an Amicon
Ultracentrifugal filter (3 kDa cut-off). Peptide concentrations
were determinedwith a Pierce BCAProtein Assay Kit (Thermo
Scientific) at 584 nm.
Purification of Nisin—Nisin was obtained as a lyophilized
powder from a commercial source (Sigma), which contains
2.5% (w/w) nisin. The active nisin was purified as described
elsewhere (41). In brief, about 1.3 g of powder (corresponding
to32 mg of nisin) was diluted in 100 ml of 50 mM lactic acid,
pH 3, and filtered through a 0.45-m membrane filter (Pall
Corporation). The nisin solution was then applied to a 5-ml
HiTrap SP HP ion exchange column (GE Healthcare) using a
flowof 2ml/min.After binding, the columnwaswashedwith 50
mM lactic acid, pH 3, until a stable base line was reached. The
elution was performed by block elution in which the NaCl con-
centration was increased from 0 to 1 M in 200mM steps. Protein
elution was monitored at 215 nm and fractions were analyzed
by SDS-PAGE. Active nisin eluted at 400 mM NaCl. Nisin con-
taining fractions were pooled, and protein was precipitated
with 25% (v/v) trichloroacetic acid overnight at 4 °C. Precipi-
tated protein was washed two times with ice-cold acetone to
remove residual NaCl and TCA and then suspended in 50 mM
lactic acid, pH 3. Peptide concentrations were determined with
a Pierce BCA Protein Assay Kit (Thermo Scientific) at 584 nm.
HPLC Analysis of Prenisin and Its Derivatives—Analytical
RP-HPLC was performed with a LiChrospher WP 300 RP-18
end capped column (Merck) at room temperature. Purified pre-
nisin or nisin were injected at a concentration of 50 M and
eluted by mixing the aqueous buffer A (10% acetonitrile, 0.1%
(v/v) trifluoroacetic acid) with the organic solvent buffer B (90%
acetonitrile, 0.1% (v/v) trifluoroacetic acid). Elution was per-
formed by applying a gradient of 0–100% of buffer B over the
course of 60 min at a flow rate of 1 ml/min. The eluent was
monitored by measuring the absorbance at 220 nm.
Static Light Scattering—Size exclusion chromatography
(SEC)2 and multiangle light scattering were performed in line on
an A¨kta purifier (GEHealthcare) connected to a triple-angle light
scattering detector (miniDawnTM TREOS, Wyatt Technology)
and a differential refractive index detector (Optilab rEX, Wyatt
Technology). SEC was performed using an analytical Superdex
200 10/300 column (GE Healthcare) equilibrated with 50 mM
HEPES-NaOH,pH7.4, and250mMNaCl.Theprotein concentra-
tionof thepurifiedNisB inelutionbufferwas2mg/ml,whereas the
sample volume was 100 l. Data were analyzed with the ASTRA
software package (Wyatt Technology).
Interaction Studies Using SEC—For complex formation, 10
l of a 300 M solution of purified prenisin or nisin (in 50 mM
HEPES-NaOH, pH 7, 1 M NaCl, and 10% (v/v) glycerol) was
mixed with 100 l of 15 M purified NisB (in 50 mM HEPES-
NaOH, pH 8, 500 mM NaCl, and 10% (v/v) glycerol), giving a
molar ratio of 2:1. Complex formation was allowed to proceed
for 1 h at room temperature. Next, the samples were applied to
a Superdex 200 pc 3.2/30 size exclusion column on an A¨KTA
micro (GE Healthcare) system at 4 °C using 50 mM HEPES-
2 The abbreviations used are: SEC, size exclusion chromatography; SPR, surface
plasmon resonance; IMAC, immobilizedmetal ion affinity chromatography.
NisB Interacts with Prenisin in Vitro
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NaOH, pH 7.4, and 500 mM NaCl as elution buffer. Protein
elution was monitored at 215 and 280 nm and the co-elution of
NisB and prenisin was analyzed by SDS-PAGE. Protein was
visualized by silver staining.
Surface Plasmon Resonance (SPR) Measurements—All mea-
surements were performedwith a Biacore X (GEHealthcare) at
25 °C and at a constant flow rate of 30 l/min using a nitrilotri-
acetic acid sensor chip (GE Healthcare). The SPR buffer was
composed of 50 mM HEPES-NaOH, pH 7.4, 250 mM NaCl, and
50M EDTA. Prior to immobilization of His-taggedNisB, both
flow cells were saturated with Ni2 by injecting 5 l of a 10 mM
Ni2 solution at a flow rate of 10 l/min. For immobilization,
purified NisB was diluted in SPR buffer to a final concentration
of 170 nM, whereupon 5 l was injected on flow cell 2 with a
flow rate of 10l/min. The first flow cell was left with just Ni2
as reference. Prenisin and its derivatives (including active nisin
and the FNLD/AAAA mutant) were diluted from stock solu-
tions in SPR buffer to final concentrations ranging from 46 nM
to 2.9 M. Due to the low binding responses of the fully modi-
fied prenisin, higher concentrations were tested in addition,
with no apparent effect on the kinetic constants and the affinity
(data not shown). For each peptide concentration, 50 l of the
prenisin samples were injected at a flow rate of 30 l/min. Sen-
sorgrams were recorded for 250 s. After every analyte injection,
the chip surface was regenerated by injecting successively 10l
of 350 mM EDTA, 10 l of 100 mM NaOH, and 10 l of 0.5%
(w/v) SDS at a flow rate of 10 l/min. Subsequently NisB was
immobilized again as described above. All sensorgrams pre-
sented are corrected for background and bulk flow effects. Each
measurement was repeated at least three times. Data were ana-
lyzed using BIAevaluation 4.1 software (GE Healthcare)
according to the Equation 1, which describes the association,
Equation 2, which describes the dissociation, and Equation 3,
which describes the dissociation constant, KD, as reported in
Ref. 32. Where dR/dt is the binding rate, kon is the association
rate, C is the concentration of injected analyte, Rmax is propor-
tional to the ligand concentration, R is proportional to the
formed ligand-analyte complex, and koff is the dissociation rate.
dR
dt
 kon C  Rmax R koff R (Eq. 1)
dR
dt





As the binding responses fromSPRmeasurements correlates to
the mass of molecules bound to the surface, the stoichiometry





Where the analyte binding capacity Rmax can be extrapolated
from experimental data and the immobilized ligand responseRl
is obtained directly from a sensorgram recorded during ligand
immobilization.
RESULTS
Purification of NisB and Prenisin Peptides—Nisin biosynthe-
sis requires the dehydrataseNisB to interact intimately with the
nisin precursor peptide. To investigate the interaction of NisB
and the nisin precursor peptide in vitro, NisB and unmodified
prenisin and several modified derivatives thereof, were purified
to homogeneity. NisB carrying a carboxyl-terminalHis6 tagwas
expressed in L. lactis, and purified from the cytosol using
immobilized metal ion affinity chromatography (IMAC) fol-
lowed by SEC. After IMAC, NisB (120 kDa) and two contam-
inants (90 and30 kDa) were present (Fig. 2, lane 4). These
contaminants turned out to be degradation products ofNisB, as
determined by immunoblotting and mass spectrometry (data
not shown), and could be removed by subsequent SEC (Fig. 2,
lane 5). Thus, NisB could be purified to homogeneity from the
cytosol with a typical yield of 1.5mg ofNisB/liter of cell culture.
Notably, in buffer containing 50 mM HEPES-NaOH, pH 8, 500
mM NaCl, and 10% (v/v) glycerol, NisB was stable for at least 1
week at 4 °C as demonstrated by SEC, where no change in the
elution profile occurred, and SDS-PAGE analysis (data not
shown).
Next, the unmodified prenisin and several of its modified
derivatives including the dehydrated and the fully modified
prenisin and the FNLD/AAAA mutant (see also Fig. 1) were
purified from the culture medium by ion exchange chromatog-
raphy (see “Experimental Procedures”).Nisin on the other hand
was purified from a commercial powder (Sigma). SDS-PAGE
analysis of SP-Sepharose fractions and subsequent silver stain-
ing revealed that the various peptide preparations were pure
(Fig. 3A). Subsequent mass spectrometry confirmed the
expected masses for the purified peptides (data not shown).
Mass spectrometry can, however, not directly distinguish
between dehydrated prenisin and the fully modified prenisin as
these peptides have identical masses: 5688 Da (peptide without
initiating methionine, see also Ref. 30). We therefore sought a
FIGURE 2. Purification of NisB. SDS-PAGE analysis of the purification of NisB.
M, molecular mass marker proteins (kDa); lane 1, supernatant after high-
speed centrifugation of L. lactis cell lysate; lane 2, flow-through of IMAC; lane
3, 50 mM imidazole IMAC wash; lane 4, 250 mM imidazole IMAC step elution;
and lane 5, NisB after size exclusion chromatography. The arrow indicates
NisB, whereas the asterisksmark the NisB degradation products.
NisB Interacts with Prenisin in Vitro
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simple and direct method to discriminate between these pep-
tides. For this, the different prenisin peptides were analyzed by
RP-HPLC (Fig. 3B). Nisin and the different prenisin peptides
were injected separately at a concentration of 50M. Increasing
the acetonitrile concentration eluted the peptides. Interest-
ingly, the peptides showed markedly different elution profiles,
which relates to significant differences in their hydrophobicity
(Fig. 3B). The unmodified prenisin eluted between 19.0 and
20.5 min as a broad peak (Fig. 3B, black curve), whereas the
dehydrated prenisin eluted in a similar broad peak but at a
substantially later retention time of 19.5–22.5 min (Fig. 3B, red
curve). Compared with the unmodified prenisin, the dehy-
drated prenisin showed reproducibly a higher absorbance at
220 nm likely due to the presence of an increased amount of
double bonds as a result of the dehydration of the serine and
threonine residues, which contribute to the absorbance at 220
nm (35). The fully modified prenisin eluted at 22.5 min and
showed a characteristic double peak (Fig. 3B, blue curve). Nisin
also showed a characteristic double peak but eluted much later
from the column as compared with the fully modified prenisin,
i.e. at 26.3 min (Fig. 3B, green curve). The double peak of nisin
has been observed before and has been attributed to a small
number of nisin molecules in which Ser-33 has escaped NisB-
mediated dehydration (19). Taken together, these data demon-
strate that RP-HPLC can be used to assess the identity of the
different prenisin peptides in a qualitative manner. Impor-
tantly, RP-HPLC is able to distinguish directly between the
dehydrated prenisin and the fullymodified prenisin, which is in
clear contrast to mass spectrometry and important for subse-
quent analysis.
NisB Is a Dimer in Solution—The purified components in
hand allow the study of the interaction between NisB and pre-
nisin in vitro. However, whereas NisB analyzed by SDS-PAGE
exhibits the expected molecular mass of120 kDa (the calcu-
lated mass of His-tagged NisB is 118.3 kDa), we noticed that
during preparative SEC NisB eluted as a protein with a molec-
ular mass of173 kDa (elution volume 59.6 ml). We therefore
determined the molecular mass of NisB in solution using mul-
tiangle static light scattering. For this, NisB was loaded on a
Superdex 200 10/300 column and the eluted protein was ana-
lyzed using a triple-angle light scattering detector. SEC com-
bined with multiangle static light scattering revealed that the
purified NisB eluted as a homogenous species with a molecular
mass of 238.0  1.2 kDa (Fig. 4, top panel). Analysis by SDS-
PAGE confirmed that onlyNisBwas present in this peak (Fig. 4,
bottom panel). Thus, under the tested conditions, NisB is pres-
ent as a dimer (calculated molecular mass for the NisB-His6
dimer is 236.6 kDa).
NisB-Prenisin Interaction Studied with SEC—To investigate
the interaction of the various prenisins with NisB, analytical
SEC studies were performed. For this, NisB was incubated with
the unmodified, dehydrated, or the fully modified prenisin for
1 h to allow complex formation. The protein mixtures were
then subjected to SEC analysis. In addition, the interaction of
NisB with the FNLD/AAAA prenisin mutant as well as active
nisin was investigated. Whereas NisB is readily detected at 280
FIGURE 3. Purification and RP-HPLC analysis of prenisin and prenisin-de-
rivedpeptides.A, SDS-PAGEanalysis of purificationof indicatedpeptides.M,
molecular mass marker proteins (kDa); lane 1, unmodified prenisin; lane 2,
dehydrated prenisin; lane 3, fully modified prenisin; lane 4, FNLD/AAAA pre-
nisin mutant; lane 5, active nisin. Proteins were visualized by silver staining.
B, RP-HPLC elution profiles of the purified peptides. Elution profiles as a func-
tion of time are shown for unmodified prenisin (black), dehydrated prenisin
(red), fully modified prenisin (blue), and nisin (green). Left y axis shows the
absorbance at 220 nm for unmodified and dehydrated prenisin. Right y axis
shows the absorbance at 220 nm for fully modified prenisin and active nisin.
FIGURE4.Sizeexclusionchromatographyandstatic light scatteringanal-
ysis of NisB. Top panel, NisB elution profile (black line) with determined
molecular mass (gray line); bottom panel, SDS-PAGE analysis of the NisB peak
fractions.
NisB Interacts with Prenisin in Vitro
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nm, the prenisin peptides are not, due to a lack of Trp and Tyr
residues. The peptides could, however, be detected at 215 nm.
Incubation of NisB with the various peptides and subsequent
SEC analysis did not reveal significant changes in the elution
behavior of NisB (data not shown). However, when NisB was
incubatedwith the dehydrated prenisins, subsequent SEC anal-
ysis showed a small decrease in absorbance at 215 nm for the
free dehydrated prenisin suggesting that some of the dehy-
drated prenisin molecules may be bound to NisB. To verify if
NisB is able to bind prenisin, the NisB peak fraction was ana-
lyzed by SDS-PAGE for co-elution of the different peptides (Fig.
5). SDS-PAGE analysis demonstrated that the unmodified,
dehydrated, and the fullymodified prenisin co-elutedwithNisB
(Fig. 5, left panels, lanes 3, 5, and 7, respectively), indicating that
these peptides form a complex with NisB. The amount of the
various prenisin forms co-eluting with NisB differed substan-
tially. The dehydrated prenisin was reproducibly present in the
highest amount, whereas a somewhat lower amount of unmod-
ified prenisin was observed. In contrast, only very low amounts
of fully modified prenisin were observed to co-elute with NisB.
Active nisin, which lacks the leader peptide and is therefore not
expected to bind to NisB, indeed did not co-elute with NisB
(Fig. 5, right panels, lane 2). To further address the importance
of the leader peptide in prenisin binding to NisB, a prenisin
mutant, in which the conserved FNLD box within the leader
peptide was mutated to AAAA, was also analyzed. This FNLD/
AAAA prenisin is secreted in low levels into the culture
medium by L. lactis cells harboring nisBTC, but is apparently
not modified (24). Interestingly, the FNLD/AAAA prenisin did
not co-elutewithNisB, suggesting that it did not to bind toNisB
(Fig. 5, right panels, lane 4). Taken together these data indicate
that NisB shows functional binding of its native substrate in
vitro and that this activity strictly depends on the presence of an
intact leader peptide.
NisB-Prenisin Interaction Studied with SPR—To character-
ize the interaction of NisB with the various prenisin peptides in
more detail, the binding was quantitatively assessed by SPR.
Measurements were performed by immobilizing NisB carrying
a C-terminal His tag onto a Ni2-bound nitrilotriacetic acid
surface, after which the different peptides were injected at var-
ious concentrations. The peptide was injected for 100 s and
sensorgrams were recorded for 250 s (Fig. 6). The real-time
binding responses showed an exponential association and an
exponential dissociation phase for the unmodified, dehydrated,
and the fully modified prenisin (Fig. 6, A–C, respectively). The
data were fitted by a 1:1 binding model with drifting baseline
and local fitted Rmax. The obtained association and dissociation
rate constants as well as the calculated equilibrium binding
constants are summarized in Table 1. The unmodified prenisin
exhibits an association rate (kon) of 1.2 0.4 104 M1 s1 and
a dissociation rate (koff) of 0.0117  0.0014 s1. Dehydrated
prenisin on the other hand showed a4-fold higher kon (5.1
1.4 104 M1 s1), but similar koff (0.0149 0.0025 s1). The
fully modified prenisin displayed a kon of 3.1  0.4  104 M1
s1 and a more than 20-fold higher koff of 0.323  0.035 s1,
when compared with the dehydrated and unmodified prenisin.
The equilibrium constant or binding affinity (KD) for the differ-
ent peptides were all found to be in the low micromolar range.
The KD for the unmodified, dehydrated, and the fully modified
prenisin peptides were 1.05 0.25, 0.31 0.07, and 10.5 1.7
M, respectively. Thus, NisB binds the dehydrated prenisin
with highest affinity, whereas the affinity for fullymodified pre-
nisin is 30-fold lower. These results are in line with the SEC
experiments where the amount of the different prenisin pep-
tides that co-elutedwithNisB followed the order: dehydrated	
unmodified	 fullymodified (Fig. 5). Consistent with SEC anal-
FIGURE 5.Complex formationbetweenNisB andprenisin. SDS-PAGE anal-
ysis of the NisB peak fractions after size exclusion chromatography showing
interactionbetweenNisBand thedifferentprenisins. Left panels,M,molecular
mass marker proteins (kDa); lane 1, purified NisB (2.5 M); lane 2, purified
unmodified prenisin (7 M); lane 3, co-elution of unmodified prenisin and
NisB; lane 4, purified dehydratedNisA (7M); lane 5, co-elution of dehydrated
prenisin andNisB; lane 6, purified fullymodifiedprenisin (7M); lane 7, co-elu-
tion of fully modified prenisin and NisB. Note, due to the presence of free
cysteines inunmodifiedanddehydratedprenisin, oxidativeproducts (bottom
panels, upper prenisin band) are often observed. Right panels; lane 1, purified
active nisin (7 M); lane 2, NisB incubated with nisin; lane 3, purified FNLD/
AAAA prenisin (7 M); lane 4, NisB incubated with FNLD/AAAA prenisin.
FIGURE 6. SPR analysis of the interaction of NisB with prenisin. Sensor-
grams showing the interaction of immobilizedNisBwith unmodified prenisin
(A), dehydrated prenisin (B), fully modified prenisin (C), nisin (D), and the
FNLD/AAAA prenisin mutant (E). Injected peptide concentrations, from bot-
tom to top, were 46 nM, 183 nM, 731 nM, 1.5 M, and 2.9 M.
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ysis, mature nisin essentially did not bind to NisB. Only at the
highest concentration tested was a very weak binding response
observed (Fig. 6D). Similarly, the unmodified prenisin carrying
the FNLD/AAAAmutation did not bind toNisB (Fig. 6E). Thus
the data indicate that the leader peptide, and especially the
FNLD box herein, is essential for binding of prenisin to NisB.
Moreover, NisB shows substrate specificity as it binds its natu-
ral substrate, i.e. the unmodified prenisin and its modified
derivatives, i.e. the dehydrated and the fully modified prenisin
with different affinity.
SPR binding responses are generally proportional to mass
and therefore one can assess the stoichiometry of an interaction
by comparing the amount of ligand immobilized to the amount
of analyte that it can bind. The stoichiometry of the interaction
of NisB with the different prenisin peptides was determined
using Equation 4 (33, 34). The Rmax (maximum capacity for
analyte binding) is a local fitted parameter and depends on the
amount of immobilized NisB. Because NisB was freshly immo-
bilized for each measurement and its immobilized levels dif-
fered somewhat for each measurement, the average values of
Rmax and Rl were used. Assuming that the immobilized NisB is
dimeric (236.6 kDa), the calculated binding stoichiometry for
the unmodified, dehydrated, and the fully modified prenisin
were found to be 0.9 0.1, 0.8 0.1, and 0.9 0.1, respectively.
DISCUSSION
The antibiotic potency of nisin seems to relate to its structure
and dual mode of action. Nisin contains structural elements
called (methyl)lanthionine rings that are important for binding
to lipid II, an essential precursor molecule of the bacterial cell
wall (6–8). Upon binding to lipid II, cell wall synthesis is
blocked and nisin pores are formed that permeabilize the cyto-
plasmic membrane (6–8). The (methyl)lanthionine rings in
nisin are installed posttranslationally by the cooperative action
of the serine/threonine-specific dehydratase NisB and the
cyclase NisC (21). Recently such lantibiotic modification
enzymes have gained special interest as they can be successfully
exploited to enhance the stability and activity of therapeutic
peptides (26, 27). Moreover, a molecular understanding of the
reactions catalyzed by these enzymesmay further aid the devel-
opment of novel and improved antibiotics.
From combined in vivo and in vitro studies it is known that
the proteins involved in nisin biosynthesis, i.e. the dehydratase
NisB, cyclase NisC, transporter NisT, and the leader peptidase
NisP can act independent of each other (17–19, 22). The dehy-
dration of the nisin precursor peptide catalyzed by NisB pres-
ents an early step in nisin maturation and is thus critical for
nisin biosynthesis (Fig. 1). In vivo studies have demonstrated
thatNisB is promiscuous as it is able to dehydrate amultitude of
nisin derivatives and even therapeutic peptides non-related
to nisin (13, 22). However, for targeting such peptides to NisB
the nisin leader peptide is required (13, 22). Unfortunately
detailed information about the actual dehydration reaction is
lacking. Moreover, no structure of NisB is available and recon-
stitution of in vitro activity of NisB has, thus far, been unsuc-
cessful. In contrast, NisC cyclase activity has been successfully
reconstituted in vitro and its crystal structure is available (15).
Here, we developed an in vitro binding assay to investigate
the interaction between the lantibiotic dehydrataseNisB and its
native substrate the unmodified prenisin, as well as its dehy-
drated and fully modified derivatives. For this, NisB was
expressed in its natural host L. lactis and purified to homoge-
neity (1.5 mg/liter of cell culture), whereas the substrate pep-
tides were purified directly from minimal medium (Fig. 2).
Interestingly, NisB purified from the cytosol proved to be
dimeric as determined by static light scattering. The dimer was
shown to be very stable as even after a week of storage no dis-
sociation or aggregation were observed. To our knowledge, this
is the first report that shows a NisB self-interaction. A study
that combined a yeast two-hybrid screen with co-immunopre-
cipitations revealed interactions betweenmembers of the puta-
tive nisin synthase complex (NisA,NisB,NisC, andNisT) (9). In
this study, a NisB self-interaction was, however, not observed.
For the yeast two-hybrid screen fragments of NisB were used
rather than full-length NisB. It is therefore intriguing to specu-
late that the self-interaction occurs only when full-length NisB
is present. For SpaB, a NisB homolog from Bacillus subtilis that
catalyzes the dehydration of the lantibiotic subtilin, a self-inter-
action was demonstrated by yeast two-hybrid analysis and the
in vitro association of His6-SpaB and Myc-SpaB (36, 37). The
proposed subtilin synthase complex consists of two molecules
each of SpaB, SpaC, and SpaT, whereas the assumed nisin syn-
thase complex consists of only oneNisBmolecule and twomol-
ecules each of NisC and NisT (9, 36, 37). Our data raises the
possibility that in the nisin synthase complex NisB is present as
a dimer. Although a body of evidence exists that supports the
existence of such multimeric lanthionine synthase complexes,
direct isolation of these complexes, and thereby the determina-
tion of the stoichiometry of the involved proteins has so far
been unsuccessful.
The isolated dimeric NisB exhibited biological activity in
vitro as it binds its native substrate, the unmodified prenisin, as
evidenced by SEC and SPR analysis (Figs. 5 and 6). The interac-
tion between NisB and the unmodified prenisin occurred with
an affinity of 1.05 0.25M (Table 1). Notably, binding toNisB
did not require special additives and occurred in the absence of
a cellular membrane. These results are consistent with yeast
two-hybrid analysis and co-immunoprecipitation studies that
showed an interaction between NisB and unmodified prenisin
(9). The modified versions of prenisin, i.e. the dehydrated and
the fullymodified form,were also boundbyNisB, althoughwith
different affinity (Figs. 5 and 6). Dehydrated prenisin, carrying
eight dehydrated residues, showed a 3-fold higher affinity as
comparedwith the unmodified prenisin, which relates to a sub-
stantially increased association rate (Fig. 6 and Table 1). This
can be explained by an overall increase in hydrophobic interac-
tions due to the presence of the dehydrated residues. In addi-
TABLE 1
Kinetic constants for the NisB-prenisin interaction
Peptide kon koff KD
M1 s1 s1 M
Unmodified prenisin 1.2 0.4 104 0.0117 0.0014 1.05 0.25
Dehydrated prenisin 5.1 1.4 104 0.0149 0.0025 0.31 0.07
Fully modified prenisin 3.1 0.3 104 0.323 0.035 10.5 1.7
Active nisin NBa
FNLD/AAAA prenisin NB
aNB, no binding observed under tested experimental conditions.
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tion it is possible that NisB interacts in a specific manner with
the non-leader part of prenisin. Support for this view comes
from binding experiments using the fully modified prenisin
(Figs. 5 and 6). Whereas the association rate of the fully modi-
fied prenisin was comparable with that of the unmodified and
dehydrated prenisin, this peptide dissociated 	20 times faster
(koff 0.323 0.035 s1). As a consequenceNisB exhibits amuch
lower affinity for this prenisin peptide, which harbors five
thioether rings (KD of 10.5  1.7 M). In line with this, dehy-
dration of serine and threonine residues was shown to be
favored when they are flanked by hydrophobic residues,
whereas a hydrophilic environment disfavored dehydration.
This indicates a specific interaction ofNisBwith the propeptide
(non-leader part) (29, 38). However, nisin, which is the equiva-
lent of fully modified prenisinminus the leader peptide, did not
bind toNisB (Figs. 5 and 6). This demonstrates the requirement
of the leader peptide for binding to NisB in vitro. The impor-
tance of the leader peptide for NisB recognition has been firmly
established in vivo as L. lactis cells harboring NisB can modify
nonlantibiotic therapeutic peptides fused to the nisin leader
peptide (13, 22, 23). The FNLD box within the leader peptide
(Fig. 1) is highly conserved in the precursor peptides of class I
lantibiotics (39).We show that the simultaneous substitution of
the FNLD residues in the leader peptide by alanines abolished
the interaction of prenisin with NisB in vitro (Figs. 5 and 6).
These results may explain the in vivo observation that this
mutant is secreted only in an unmodified formdespite the pres-
ence of functional NisB and NisC (24). Thus the FNLD box is
essential for prenisin interaction with NisB. However, because
the FNLD/AAAA prenisin is still secreted, this suggests that
leader peptide recognition by NisT is less stringent or deter-
mined by different part(s) of the leader peptide.
Taken together the data indicate that the nisin leader peptide
is important for recognition and initial binding toNisB, with an
essential role for the FNLD box. However, the interaction
between NisB and prenisin is not only determined by the nisin
leader peptide, but also by the nature of the propeptide (non-
leader part). Thus the dehydratase NisB shows substrate spec-
ificity in vitro, as it is able to discriminate between the unmod-
ified prenisin and its modified derivatives. Similarly, NisB may
act as the specificity determinant within the nisin synthase
complex in vivo. Following modification by NisB and NisC, the
fully modified prenisin containing the thioether rings is rapidly
released from the modification complex and subsequently
exported by NisT.
Recent characterization of a number of prenisin mutants
affected in ring formation revealed that NisB-mediated dehy-
dration and NisC cyclase activity are strongly coordinated
events. Herein, NisB and NisC alternate in function to install
the modifications in a processive and directional manner (20,
21, 30).Our in vitroobservations that thioether rings reduce the
affinity of prenisin for NisB, whereas dehydrated residues
appear to increase the affinity, would be compatible with such
an alternating mechanism. It remains, however, to be deter-
mined whether the NisB dimer is required for biological
activity.
The successful in vitro reconstitution of the enzymatic activ-
ity of several bifunctional LanM enzymes, which harbor both
dehydratase and cyclase activity, has provided us with insight
into themechanistic aspects of lantibioticmodification (31, 40).
The dehydratases of the LanB family, i.e. the lantibiotic syn-
thases, that require separate enzymes for dehydration and
cyclization remain on the other hand enigmatic. Although for
many of these LanB enzymes a role in dehydration has been
established unequivocally in vivo, this still has to be demon-
strated in the test tube (2). Therefore, future work will focus on
the aim to reconstitute the dehydratase activity of NisB in vitro.
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